These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 24093749)
1. Drug therapy of neuropathic pain: current developments and future perspectives. Muthuraman A; Singh N; Jaggi AS; Ramesh M Curr Drug Targets; 2014 Feb; 15(2):210-53. PubMed ID: 24093749 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic targets for the management of peripheral nerve injury-induced neuropathic pain. Jaggi AS; Singh N CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):589-609. PubMed ID: 21631400 [TBL] [Abstract][Full Text] [Related]
3. Antidepressants and gabapentinoids in neuropathic pain: Mechanistic insights. Kremer M; Salvat E; Muller A; Yalcin I; Barrot M Neuroscience; 2016 Dec; 338():183-206. PubMed ID: 27401055 [TBL] [Abstract][Full Text] [Related]
4. Research progress of mechanisms and drug therapy for neuropathic pain. Yan YY; Li CY; Zhou L; Ao LY; Fang WR; Li YM Life Sci; 2017 Dec; 190():68-77. PubMed ID: 28964813 [TBL] [Abstract][Full Text] [Related]
5. Uncovering new pharmacological targets to treat neuropathic pain by understanding how the organism reacts to nerve injury. Martin YB; Herradón G; Ezquerra L Curr Pharm Des; 2011; 17(5):434-48. PubMed ID: 21375486 [TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy for neuropathic pain. Jackson KC Pain Pract; 2006 Mar; 6(1):27-33. PubMed ID: 17309706 [TBL] [Abstract][Full Text] [Related]
11. New developments in the treatment algorithm for peripheral neuropathic pain. de Leon-Casasola O Pain Med; 2011 Jul; 12 Suppl 3():S100-8. PubMed ID: 21752181 [TBL] [Abstract][Full Text] [Related]
12. Managing Neuropathic Pain in Multiple Sclerosis: Pharmacological Interventions. Duffy SS; Lees JG; Perera CJ; Moalem-Taylor G Med Chem; 2018 Feb; 14(2):106-119. PubMed ID: 28875858 [TBL] [Abstract][Full Text] [Related]
13. Advances in the Treatment of Neuropathic Pain. Xu L; Zhang Y; Huang Y Adv Exp Med Biol; 2016; 904():117-29. PubMed ID: 26900067 [TBL] [Abstract][Full Text] [Related]
14. Management of peripheral neuropathic pain. Stacey BR Am J Phys Med Rehabil; 2005 Mar; 84(3 Suppl):S4-16. PubMed ID: 15722782 [TBL] [Abstract][Full Text] [Related]
15. KM-416, a novel phenoxyalkylaminoalkanol derivative with anticonvulsant properties exerts analgesic, local anesthetic, and antidepressant-like activities. Pharmacodynamic, pharmacokinetic, and forced degradation studies. Kubacka M; Rapacz A; Sałat K; Filipek B; Cios A; Pociecha K; Wyska E; Hubicka U; Żuromska-Witek B; Kwiecień A; Marona H; Waszkielewicz AM Eur J Pharmacol; 2020 Nov; 886():173540. PubMed ID: 32896552 [TBL] [Abstract][Full Text] [Related]
16. [Therapeutic advances in pharmaceutical treatment of neuropathic pain]. Attal N Rev Neurol (Paris); 2011 Dec; 167(12):930-7. PubMed ID: 22100325 [TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components. Morlion B Curr Med Res Opin; 2011 Jan; 27(1):11-33. PubMed ID: 21083513 [TBL] [Abstract][Full Text] [Related]